1. Glagolev S.V., Gorelov K.V., Chizhova D.A. Razvitie sistemy farmakonadzora v Rossijskoj Federacii [Development of the pharmacovigilance system in the Russian Federation]. Vestnik Roszdravnadzora [Bulletin of Roszdravnadzor]. 2019;(2):72–77. (In Russian).
2. Zhuravleva M.V., Romanov B.K., Gorodeckaya G.I., Muslimova O.V., Krysanova V.S., Demchenkova E. Yu. Aktual’nye voprosy bezopasnosti lekarstvennyh sredstv, vozmozhnosti sovershenstvovaniya sistemy farmakonadzora [Topical issues of drug safety, possibilities of improving of pharmacovigilance]. Bezopasnost’ i risk farmakoterapii [Safety and Risk of Pharmacotherapy]. 2019;7(3):109–119. (In Russian). DOI: 10.30895/2312-7821-2019-7-3-109-119.
3. Hoseva E.N., Morozova T.E., Ermakov D.A., Oshorova S.D. Voprosy kontrolya bezopasnosti lekarstvennoj terapii v shirokoj klinicheskoj praktike: pozicii pacientov i medrabotnikov [The issues of monitoring the safety of drug therapy in clinical practice: positions of patients and medical workers]. Vrach-aspirant [The Doctor Post-Graduate Student]. 2013;2.1(57):203–212. (In Russian).
4. Shubnikova E.V., Darmostukova M.A., Bukatina T.M., Kaperko D.A., Vel’ts N.Yu., Kazakov A.S., et al. O zaregistrirovannyh v postmarketingovyj period nezhelatel’nyh reakciyah lekarstvennyh sredstv [The adverse drug reactions registered during the postmarketing period]. Bezopasnost’ i risk farmakoterapii [Safety and Risk of Pharmacotherapy]. 2019;7(1):15–22. (In Russian). DOI: 10.30895/2312-7821-2019-7-1-15-2.
5. Ahern F., Sahm L.J., Lynch D., McCarthy S. Determining the frequency and preventability of adverse drug reaction related admissions to an Irish University Hospital: a cross sectional study. Emerg. Med. J. 2014;31:24–29.